Display options
Cite
Park HS, Kim KM, Joung KW, et al. Monitored anesthesia care with dexmedetomidine in transfemoral percutaneous trans-catheter aortic valve implantation: two cases report. Korean J Anesthesiol. 2014;66(4):317-21doi: 10.4097/kjae.2014.66.4.317.
Park, H. S., Kim, K. M., Joung, K. W., Choi, I. C., & Sim, J. Y. (2014). Monitored anesthesia care with dexmedetomidine in transfemoral percutaneous trans-catheter aortic valve implantation: two cases report. Korean journal of anesthesiology, 66(4), 317-21. https://doi.org/10.4097/kjae.2014.66.4.317
Park, Hee-Sun, et al. "Monitored anesthesia care with dexmedetomidine in transfemoral percutaneous trans-catheter aortic valve implantation: two cases report." Korean journal of anesthesiology vol. 66,4 (2014): 317-21. doi: https://doi.org/10.4097/kjae.2014.66.4.317
Park HS, Kim KM, Joung KW, Choi IC, Sim JY. Monitored anesthesia care with dexmedetomidine in transfemoral percutaneous trans-catheter aortic valve implantation: two cases report. Korean J Anesthesiol. 2014 Apr;66(4):317-21. doi: 10.4097/kjae.2014.66.4.317. Epub 2014 Apr 28. PMID: 24851170; PMCID: PMC4028562.
Copy Download .nbib Format: NLM
Share it on

Korean J Anesthesiol. 2014 Apr;66(4):317-21. doi: 10.4097/kjae.2014.66.4.317. Epub 2014 Apr 28.

Monitored anesthesia care with dexmedetomidine in transfemoral percutaneous trans-catheter aortic valve implantation: two cases report.

Korean journal of anesthesiology

Hee-Sun Park, Kyung-Mi Kim, Kyoung-Woon Joung, In-Cheol Choi, Ji-Yeon Sim

Affiliations

  1. Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

PMID: 24851170 PMCID: PMC4028562 DOI: 10.4097/kjae.2014.66.4.317

Abstract

Percutaneous trans-catheter aortic valve implantation (TAVI) is recommended for inoperable patients with severe aortic stenosis at high risk for conventional aortic valve replacement. Originally, TAVI was mostly performed under general anesthesia. Here we describe two cases of transfemoral TAVI performed under monitored anesthesia care (MAC) with dexmedetomidine. Dexmedetomidine provides sedation, analgesia with minimal respiratory depression. Although MAC during transfemoral TAVI has limitations, such as unexpected patient movement and difficulty in intra-procedural use of transesophageal echocardiography, MAC with dexmedetomidine is feasible with close monitoring, fluoroscopic guidance and the participation of experienced anesthesiologists.

Keywords: Anesthesia; Dexmedetomidine; Heart valve prosthesis implantation; Hypnotics and Sedatives

References

  1. Cardiovasc Revasc Med. 2012 Jul-Aug;13(4):207-10 - PubMed
  2. J Cardiothorac Vasc Anesth. 2009 Jun;23(3):280-5 - PubMed
  3. J Am Coll Cardiol. 2012 Mar 27;59(13):1200-54 - PubMed
  4. Anesthesiology. 2000 Nov;93(5):1336-44 - PubMed
  5. Pharmacotherapy. 2005 May;25(5 Pt 2):8S-18S - PubMed
  6. Korean J Anesthesiol. 2011 Feb;60(2):128-33 - PubMed
  7. Am Heart J. 2010 Mar;159(3):497-503 - PubMed
  8. Anesth Analg. 2010 Jan 1;110(1):47-56 - PubMed
  9. Anesthesiology. 2006 Nov;105(5):902-10; quiz 1069-70 - PubMed
  10. Catheter Cardiovasc Interv. 2008 Dec 1;72(7):1012-5 - PubMed
  11. Minerva Anestesiol. 2010 Feb;76(2):100-8 - PubMed
  12. Anaesthesia. 2011 Nov;66(11):977-82 - PubMed
  13. Clin Res Cardiol. 2012 Jan;101(1):45-53 - PubMed
  14. Anesth Analg. 2008 Jan;106(1):79-83, table of contents - PubMed
  15. Circulation. 2002 Dec 10;106(24):3006-8 - PubMed

Publication Types